Multidisciplinary Care for Anaplastic Thyroid Cancer—End‐of‐Life Care as a Standard of Care
The Laryngoscope · 2025
DOI: 10.1002/lary.32243 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Haidee Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, David Geffen School of Medicine, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Terminal Care, Palliative Care, Thyroid Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDCD NIH HHS, National Institute on Deafness and Other Communication Disorders.
Abstract (Originalsprache)
Objectives
Anaplastic thyroid cancer ( ATC ) is an aggressive and potentially fatal thyroid malignancy. Clinical guidelines recommend that all ATC patients be evaluated by a multidisciplinary team, including palliative care specialists, with treatment decisions reflecting patients' evolving goals of care ( GOC ). This study aimed to investigate patterns of palliative care referrals and GOC documentation in advanced ATC patients treated with newer targeted therapies and immunotherapies.
Methods
Retrospective cohort study of 58 ATC patients diagnosed between 2000 and 2023 at a single quaternary medical center. Data on demographics, treatments, palliative care referrals, and GOC discussions were collected by chart review and analyzed using Fisher's exact test, Wilcoxon rank‐sum tests, Kaplan–Meier survival analysis, and multivariate logistic regression.
Results
Mean age at diagnosis was 69.2 years, with 50% female. A minority of patients were referred to palliative care a median of 45 days before death. Only 36.2% had a documented GOC discussion, with the first occurring a median of 53 days post‐diagnosis. Targeted therapy/immunotherapy was significantly associated with palliative care referrals ( p = 0.004) and radiotherapy with GOC discussions ( p < 0.001). Multivariate regression showed that targeted therapy/immunotherapy was independently associated with palliative care referral ( p = 0.04).
Conclusions
Despite national guidelines, many ATC patients do not receive timely palliative care referrals. The relationship between targeted therapies and higher rates of palliative care referrals and GOC discussions merits further study. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, David Geffen School of Medicine, Los Angeles, California, USA.
- University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- Department of Medicine, Section of Palliative Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
ORCID-Profile: Haidee Chen, Christian Schaaff, Eugene Oh, Maie St John
Förderung
- NIDCD NIH HHS
- National Institute on Deafness and Other Communication Disorders
Zitieren
APA
Chen, H., Evans, L., Schaaff, C., Labib, M., Oh, E., Ashendouek, M., Sajed, D., Ho, W. C., Wong, D. J., Martin, E. J., & St John, M. (2025). Multidisciplinary Care for Anaplastic Thyroid Cancer—End‐of‐Life Care as a Standard of Care. The Laryngoscope. https://doi.org/10.1002/lary.32243
Vancouver
Chen H, Evans L, Schaaff C, Labib M, Oh E, Ashendouek M, et al. Multidisciplinary Care for Anaplastic Thyroid Cancer—End‐of‐Life Care as a Standard of Care. The Laryngoscope. 2025. doi:10.1002/lary.32243
BibTeX
@article{Chen2025,
author = {Chen, Haidee and Evans, Lauran and Schaaff, Christian and Labib, Manwel and Oh, Eugene and Ashendouek, Maya and Sajed, Dipti and Ho, Wanxing Chai and Wong, Deborah J and Martin, Emily J and St John, Maie},
title = {Multidisciplinary Care for Anaplastic Thyroid Cancer—End‐of‐Life Care as a Standard of Care},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32243}
}
EUVIMED